Travere Therapeutics (TVTX) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 98.5%
EBITDA Margin: -9.2%
Op. Margin: -29.0%
Net Margin: -29.2%

Op. margin of -29.0% is up 23.2% YoY — cost efficiency is improving. Net margin at -29.2% and gross margin of 98.5% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit